Tag Archives: cholangiocarcinoma

Bile duct cancer: New hope from milk-derived nanoparticles and targeted gene therapy

New hope for bile duct cancer patients through gene-dilencing therapy.

Bile duct cancer is a rare and aggressive cancer, and new Mayo Clinic research suggests milk-derived nanoparticles may help deliver highly targeted treatment directly to tumours. This matters because many patients with bile duct cancer have limited treatment options and poor long-term outcomes. The new study focuses on cholangiocarcinoma, the …

Read More »